PAROXETINE

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID1439
Ligand NamePAROXETINE
PubMed Compound Id43815
StructureProduct Image
Molecular FormulaC19H20FNO3
Molecular Weight329.4
SMILESC1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
Synonymsparoxetine
Frosinor
Casbol
Motivan
PaxPar
Paroxetina
Paxetil
Paroxetinum
Paroxetinum [INN-Latin]
Paroxetina [INN-Spanish]
Arketis
Besitram
Daparox
Oxetine
Parogen
Xetanor
Arotin
(-)3s,4r-paroxetine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
UNII-41VRH5220H
CHEBI:7936
DTXSID3023425
41VRH5220H
Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S,4R)-
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine
Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S-trans)-
DTXCID703425
HSDB 7175
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
Paroxetinum (INN-Latin)
Paroxetina (INN-Spanish)
PAROXETINE (MART.)
PAROXETINE [MART.]
(-)-TRANS-4-(P-FLUOROPHENYL)-3-((3,4-(METHYLENEDIOXY)PHENOXY)METHYL)PIPERIDINE
(3S,4R)-3-((1,3-BENZODIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)PIPERIDINE
piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)-
Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S-trans)-
Paroxetinum (Latin)
N06AB05
61869-08-7
Seroxat
BRL 29060
(-)-Paroxetine
FG 7051
FG-7051
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
BRL-29060
(3s,4r)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(+/-)-Paroxetine
Paroxetine, (+/-)-
CHEMBL490
Paroxetine, trans-(+/-)-
32Q7TW8BX7
Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-,(3S,4R)-
(3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
110429-35-1
Paroxetine (TN)
130855-15-1
Paroxetine [USAN:INN:BAN]
CHEMBL1708
Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3R,4S)-rel-
Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, trans-
Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, trans-(+/-)-
Rel-(3R,4S)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
PAROXETINE HCL HEMIHYDRATE
CAS-61869-08-7
Paroxetine (USP/INN)
3h-paroxetine
Paroxetine.HCl
NCGC00182968-01
8PR
NNC-20-7051
Spectrum_001752
PAROXETINE [MI]
SpecPlus_000788
PAROXETINE [INN]
Prestwick3_000851
Spectrum5_001665
PAROXETINE [USAN]
PAROXETINE [VANDF]
PAROXETINE [WHO-DD]
UNII-32Q7TW8BX7
SCHEMBL27799
BSPBio_000861
KBioSS_002232
BIDD:GT0673
DivK1c_006884
BPBio1_000949
GTPL4790
BDBM22416
KBio1_001828
KBio2_002232
KBio2_004800
KBio2_007368
HMS2090H05
Tox21_113123
BDBM50331515
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine
AKOS015888636
Tox21_113123_1
AC-8185
DB00715
SDCCGSBI-0051908.P003
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine
(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine
NCGC00025355-02
NCGC00025355-03
NCGC00025355-04
NCGC00025355-05
NCGC00025355-06
NCGC00025355-07
NCGC00025355-08
NCGC00025355-09
NCGC00025355-12
NCGC00025355-13
NCGC00025355-22
NCGC00025355-23
SBI-0051908.P002
HY-122272
AB00514724
CS-0083299
NS00000037
C07415
D02362
EN300-150199
AB00053704-21
AB00053704_22
AB00053704_23
paroxetine hydrochloride (anhydrous or hemihydrate)
Q408471
BRD-K37991163-003-02-7
BRD-K37991163-003-13-4
BRD-K37991163-003-14-2
BRD-K37991163-050-05-1
BRD-K37991163-050-18-4
(3S,4R)-3-[(1,3-dioxaindan-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm